Eugene A. Zhukovsky - Concepedia

Author

Eugene A. Zhukovsky

Brandeis University ORCID

Also Known As

E A Zhukovsky, E Zhukovsky, E. Zhukovsky, Eugene A Zhukovsky, Eugene A. Zhukovsky, Eugene Zhukovsky

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Brandeis University Affimed Therapeutics (Germany)Xencor (United States)Johns Hopkins University Christian-Albrechts-Universität zu Kiel

About

Eugene A. Zhukovsky is an author at Brandeis University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	777
2	Natural Sciences	2	2	631
3	Biochemistry	2	2	631
4	Social Sciences	1	1	45
5	Allergy	1	1	158

Eugene A. Zhukovsky

Publications

2.5K

Citations

H-Index

Page 1

	Year	Citations
Constitutively active mutants of rhodopsin Phyllis R. Robinson, George B. Cohen, Eugene A. Zhukovsky, Neuron Protein FunctionBiochemistryNatural SciencesBiochemical GeneticsMolecular Biology	1992	515
Effect of Carboxylic Acid Side Chains on the Absorption Maximum of Visual Pigments Eugene A. Zhukovsky, Daniel D. Oprian Science	1989	477
Potent <i>In vitro</i> and <i>In vivo</i> Activity of an Fc-Engineered Anti-CD19 Monoclonal Antibody against Lymphoma and Leukemia Holly M. Horton, Matthew J. Bernett, Erik Pong, Cancer Research	2008	267
Inactivation of TNF Signaling by Rationally Designed Dominant-Negative TNF Variants Paul M. Steed, Malú G. Tansey, Jonathan Zalevsky, Science ImmunologyCell DeathPathologyImmunologic MechanismImmunotherapy	2003	257
A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30<sup>+</sup>tumor cells Uwe Reusch, Carmen Burkhardt, Ivica Fucek, mAbs ImmunologyNk CellsImmunologic MechanismAntigen ProcessingImmunotherapeutics	2014	158
A tetravalent bispecific TandAb (CD19/CD3), AFM11, efficiently recruits T cells for the potent lysis of CD19<sup>+</sup>tumor cells Uwe Reusch, Johannes Duell, Kristina Ellwanger, mAbs ImmunologyImmunoeditingImmunologic MechanismImmunotherapeuticsPotent Tumor-killing Capacity	2015	125
Transducin Activation by Rhodopsin Without a Covalent Bond to the 11- <i>Cis</i> -Retinal Chromophore Eugene A. Zhukovsky, Phyllis R. Robinson, Daniel D. Oprian Science Schiff BaseTransducin ActivationMolecular BiologyRetinal ChromophorePhototropin	1991	116
The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primates Jonathan Zalevsky, Irene Leung, Sher Karki, Blood	2008	101
Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia Uwe Reusch, Kimberly H. Harrington, Chelsea J. Gudgeon, Clinical Cancer Research	2016	89
Fc-engineered anti-CD40 antibody enhances multiple effector functions and exhibits potent in vitro and in vivo antitumor activity against hematologic malignancies Holly M. Horton, Matthew J. Bernett, Matthias Peipp, Blood	2010	73

Page 1